4th International Definiens Symposium to Feature More Than 20 Expert Presenters

Speakers will discuss trends and opportunities in image and data analysis for digital pathology at Harvard Medical School in Boston

Munich, Germany, March 5, 2013 / B3C newswire / –Definiens, the global leader of image and data analysis solutions for quantitative digital pathology, today announced it will host more than 20 distinguished speakers at the 4th International Definiens Symposium, featuring discussions on image and data analysis in digital pathology. The symposium will be held at the Joseph B. Martin Conference Center on Harvard Medical School campus in Boston, MA on May 13-15, 2013.

This annual event will bring together global leading experts from pharmaceutical, biotech and diagnostics companies, as well as academic medical centers to share groundbreaking research and insights on digital pathology. Presenters will highlight how Definiens technology is used in practice to accelerate R&D and discovery of new drugs and biomarkers in automated workflows and how it can be used to innovate new diagnostic tests, increase the success rate of development, reduce time to market and manage the diversity of a broad range of image analysis tasks.

“Definiens is committed to helping researchers and clinicians generate new knowledge that supports personalized medicine and better decisions in research, diagnostics and therapy,” said Thomas Heydler, CEO of Definiens. “Advanced image and data analysis is critical to enhancing diagnostics and clinical digital pathology. We’re thrilled to be working with such an esteemed group of presenters to share knowledge that can lead to improved decision making and better outcomes for patients.”

The symposium will feature plenary talks as well as hands-on workshops to encourage collaboration and the sharing of best practices. Sessions will include:

“The Definiens symposium has become a leading forum for discussions on image and data analysis in digital pathology,” said Dr. Thomas Nifong, VP of Clinical Operations, Metamark Genetics. “It provides an important setting for sharing new academic and clinical research and promoting advancements in the industry.”

About DefiniensDefiniens is the leading provider of image analysis and data mining solutions for life sciences, tissue diagnostics and clinical digital pathology. Definiens software provides detailed cell-by-cell readouts from target structures on whole tissue slides, and allows the correlation of this information with data derived from other sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and support better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives.

Definiens is headquartered in Munich, Germany and has offices throughout the United States.